Delaware Section 203: The Three-Year Business Combination Waiting Period

Delaware Section 203 is a state-level takeover defense that freezes most mergers for three years once an acquirer accumulates 15% of a company’s shares, blocking rapid hostile takeovers unless the board approves the acquisition or the buyer meets one of three narrow exceptions.

The mechanics: how the 15% threshold triggers the moratorium

Delaware Section 203 applies to any Delaware corporation that has 30 or more shareholders. The statute activates the moment an “interested shareholder” (defined as the person or group acquiring 15% or more of voting power) crosses that threshold without prior board approval. Once triggered, the moratorium begins immediately.

During the three-year waiting period, the company cannot engage in a “business combination” with that interested shareholder. The statute defines business combination broadly: a merger, consolidation, asset sale of 10% or more of assets, liquidation, or any transaction in which the shareholder receives any benefit not offered to all shareholders equally.

The intent is transparent: give the board of directors and shareholders time to evaluate the bid, avoid stampeding into an undersized offer, and shift negotiating leverage toward the target. Without Section 203, an acquirer could, in theory, cross 15% in a matter of weeks and force a vote on a hostile merger before the board had organized a response or found an alternative bidder.

The board-approval safe harbor: the clean path

The most important exception is straightforward: if the target’s board approves the acquisition before the buyer reaches 15% ownership, Section 203 never activates. The board can agree to sell the company to a bidder, authorize the bidder to accumulate any ownership stake necessary, and proceed without delay.

This safe harbor is why hostile bids often begin with a public tender offer rather than a quiet accumulation. If the board rejects the offer, the bidder must then choose: cease accumulating shares (avoiding the Section 203 freeze), or press ahead, cross 15%, trigger the moratorium, and live with the three-year wait. Alternatively, if the board is agnostic or conflicted, the bidder may accumulate quietly up to just under 15%, then make its intentions public with a proxy fight or takeover threat, hoping to turn the board before hitting the threshold.

The supermajority exception: waiting out the clock

After three years elapse, the waiting period ends—but the deal still requires shareholder approval. Most Delaware corporations require only a simple majority of shares outstanding to approve a merger. Section 203 modifies this: if a business combination involves an interested shareholder, it requires a two-thirds shareholder vote (66.67%) unless certain conditions are met.

This is a high bar. In a dispersed public company where management controls a modest percentage of shares and an activist fund owns significant stakes, a two-thirds supermajority may be difficult to assemble. If the bidder has already crossed 15% and is now the largest single shareholder, it cannot vote its own shares to approve the deal—the supermajority is calculated on all voting shares (excluding the interested shareholder’s holdings). So a bidder holding 20% of the company would need the votes of shareholders holding at least 50% of the remaining 80% to hit two-thirds.

Practically, this means a bidder waiting out Section 203 faces a high risk that current shareholders will reject the deal three years later, or demand a higher price in exchange for the supermajority vote.

The fair-price exception: an alternative path

Delaware Section 203 includes a “fair price” exception. If the interested shareholder meets detailed procedural and valuation requirements, it may avoid the supermajority vote (though not the three-year moratorium itself). The conditions are strict:

• The business combination must offer all non-interested shareholders an identical price and form of consideration.
• The price must be determined by independent directors, a fairness opinion from a financial advisor, or a formula (like appraisal value) set out in advance.
• Shareholders must be given full disclosure and the right to dissent and seek appraisal.
• The transaction must follow specific timing and voting procedures.

In practice, the fair-price exception is complex and rarely used. Most bidders either seek board approval pre-15%, wait out the three years and negotiate a new supermajority vote, or abandon the pursuit.

Why 15%? Historical context

The 15% threshold was chosen to identify a “control accumulation” without requiring the bidder to cross the Schedule 13D threshold (5% under SEC rules), which would immediately trigger public disclosure and alert the target’s board. In the 1980s, when Delaware Section 203 was enacted, the 15% figure represented a meaningful control stake but stopped short of 50%, signaling intent without conferring outright majority power. Today, with SEC proxy access rules and activist disclosure norms, the practical secrecy window is smaller, but the statute’s 15% benchmark remains.

Opting out and variations across jurisdictions

Delaware corporations can opt out of Section 203 in their charter or bylaws, though very few do. Opting out makes a company more vulnerable to a hostile surprise and typically reduces its stock price, making the opt-out economically self-defeating for most boards.

Other states have adopted similar laws (sometimes called “business combination statutes” or “anti-takeover statutes”), though Delaware’s is the most widely relied upon, since roughly 60% of Fortune 500 companies and many more smaller public companies are incorporated in Delaware.

Interaction with other defenses

Section 203 doesn’t stand alone. Most Delaware public companies also have poison pills (shareholder rights plans that dilute an acquirer’s stake if it crosses a lower threshold, often 10–20%), staggered boards (where only one-third of directors are elected each year, slowing a bidder’s ability to take control), and shareholder voting agreements. Section 203 is the statutory backdrop; the poison pill is the tactical sharp tool.

Together, these defenses mean a hostile bidder faces a multi-layered challenge: navigate the poison pill, try to replace the board via a proxy fight (which takes time and money), wait out Section 203, and then secure a supermajority vote. Very few hostile bids succeed; most either fail, are abandoned, or evolve into negotiated deals.

Practical effect on M&A strategy

For a bidder, Section 203 is a cost—literal time cost (three years is an eternity in business), legal and advisory costs, and opportunity cost (the target may be acquired by someone else, or its value may deteriorate). The statute gives the target’s board a mandatory negotiation window. Savvy bidders either:

1. Approach the board first (avoiding Section 203 entirely).
2. Launch a proxy fight to replace the board, then request a merger vote (the new board can waive Section 203).
3. Bite the bullet, trigger the moratorium, and spend three years lobbying shareholders or negotiating a post-moratorium deal.

For target shareholders, Section 203 can be protective (preventing a too-low bid) or destructive (blocking a good deal a skeptical board opposes). The statute is neutral on that debate; it simply shifts power to the board and shareholders rather than leaving the field open to a disciplined bidder.

See also